1. Prognostic Value of the Malnutrition-inflammation Score in Hospitalization and Mortality on Long-term Hemodialysis
- Author
-
Tatiana Pinheiro, Inês Ramião, Nuno BorgesRD, Conceição Calhau, Fernando Macário, J. Pereira, Teresa Adragão, Rita Figueiredo, Pedro Lourenço, Brígida Velez, Vitor Sá Martins, Leila Aguiar, Tânia Pascoal, Catarina Dias, Iola Pinto, Ana Luisa Papoila Al, and Faculdade de Ciências da Nutrição e Alimentação
- Subjects
Male ,medicine.medical_specialty ,medicine.medical_treatment ,Nutritional Status ,Medicine (miscellaneous) ,Comorbidity ,Weight Gain ,Cohort Studies ,Renal Dialysis ,Risk Factors ,Albumins ,Diabetes mellitus ,Internal medicine ,medicine ,Humans ,Dialysis ,Aged ,Inflammation ,Nutrition and Dietetics ,business.industry ,Malnutrition ,Health sciences, Medical and Health sciences ,Ciências médicas e da saúde ,Regression analysis ,Evidence-based medicine ,Middle Aged ,Prognosis ,medicine.disease ,Hospitalization ,Nephrology ,Cohort ,Medical and Health sciences ,Female ,Ciências da Saúde, Ciências médicas e da saúde ,Hemodialysis ,business ,Historical Cohort - Abstract
Objective: Since its development, cumulative evidence has accumulated regarding the prognostic value of the Malnutrition-Inflammation Score (MIS/Kalantar score) prognostic value; however, there is a shortage of recent and large studies with comprehensive statistical methodologies that contribute to support a higher level of evidence and a consensual cutoff. The aim of this study was to assess the strength of MIS association with hospitalization and mortality in a nationwide cohort. Methods: This was a historical cohort study of hemodialysis patients from 25 outpatient centers followed up for 48 months. Univariable and multivariable Cox additive regression models were used to analyze the data. The C-index was estimated to assess the performance of the final model. Results: Two thousand four hundred forty-four patients were analyzed, 59.0% males, 32.0% diabetic, and median age of 71 years (P25 = 60, P75 = 79). During a median period of 45-month follow-up, with a maximum of 48 months (P25 = 31; P75 = 48), 875 patients presented an MIS
- Published
- 2022